| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014250 |
| Receipt No. | R000016600 |
| Public title | evaluation of CNS in muscular dystrophy |
| Date of disclosure of the study information | 2014/06/12 |
| Last modified on | 2019/03/12 (Ver. 6) |
| Basic information | ||
| Public title | evaluation of CNS in muscular dystrophy | |
| Acronym | evaluation of CNS in muscular dystrophy | |
| Scientific Title | evaluation of CNS in muscular dystrophy | |
| Scientific Title:Acronym | evaluation of CNS in muscular dystrophy | |
| Region |
|
|
| Condition | |||||
| Condition | Muscle dystrophy | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | A morphological and functional evaluation of the central nerve of patients with muscular dystrophy |
| Basic objectives2 | Others |
| Basic objectives -Others | Confirmation of the abnormal distribution of the GABA receptor using iomazenil SPECT |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We confirm a function and morphological abnormal presence |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Iomazenile SPECT/MRI/PET/EEG/clinical examination | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | The patients with muscular dystrophy | |||
| Key exclusion criteria | The person that an examination for 30-minute imaging is impossible
exclude the patients who are recognized as inadequate patients by doctors with responsibility in this study |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | University of Niigata,
Brain Research Institute |
||||||
| Division name | Center for Integrated Human Brain Science | ||||||
| Zip code | 951-8585 | ||||||
| Address | Asahimachi 1-757, Chuo-ku,Niigata | ||||||
| TEL | 025-227-0683 | ||||||
| tnakada@bri.niigata-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | University of Niigata, Brain Research Institute | ||||||
| Division name | Center for Integrated Human Brain Science | ||||||
| Zip code | 951-8585 | ||||||
| Address | Asahimachi 1-757, Chuo-ku,Niigata | ||||||
| TEL | 025-227-0683 | ||||||
| Homepage URL | |||||||
| yuji-s@bri.niigata-u.ac.jp | |||||||
| Sponsor | |
| Institute | Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata |
| Institute | |
| Department | |
| Funding Source | |
| Organization | grant from Ministry of Education, Culture, Sports, Science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | National Hospital Organization, Niigata National Hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Niigata National Hospital |
| Address | 3-52 Akasaka-cho Kashiwazaki, Niigata |
| Tel | 0257-22-2126 |
| 225sy01@hosp.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構新潟病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016600 |